{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Broomfield",
      "state": "CO",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "66373",
      "recalling_firm": "Sandoz Incorporated",
      "address_1": "2555 W Midway Blvd",
      "address_2": "N/A",
      "postal_code": "80020-1632",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-66373-001",
      "product_description": "Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.",
      "product_quantity": "25,830 bottles",
      "reason_for_recall": "Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.",
      "recall_initiation_date": "20130925",
      "center_classification_date": "20131010",
      "termination_date": "20140716",
      "report_date": "20131016",
      "code_info": "Lot #: BU3417, Exp 06/2014"
    }
  ]
}